Donald Nicholson

Donald Nicholson serves as the Executive Chairman of Nimbus Therapeutics, a BioTech company that leverages computational sciences for drug discovery in immunology, metabolic diseases, and oncology. Prior to this role, he spent 25 years at Merck, where he achieved the position of Vice President and Worldwide Discovery Head, overseeing research in immunology, respiratory, endocrine, bone, muscle, urology, and anemia. Nicholson earned his Ph.D. in Biochemistry from the University of Western Ontario and furthered his training as an MRC post-doctoral fellow at the University of Munich. He has made significant contributions to the scientific community, co-authoring over 150 publications and receiving numerous academic and professional honors. Additionally, Nicholson holds positions on the Board of Directors for several organizations, including Kymera, Generation Bio, Jnana, and NodThera.